Screener
Summit Therapeutics SMMT Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Summit Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
FAQ
- What is Summit Therapeutics's return on invested capital?
- Summit Therapeutics (SMMT) reported return on invested capital of -81.8% in Q4 2024.
- How has Summit Therapeutics's return on invested capital changed year-over-year?
- Summit Therapeutics's return on invested capital increased by 50.6% year-over-year, from -165.6% to -81.8%.
- What is the long-term trend for Summit Therapeutics's return on invested capital?
- Over 4 years (2020 to 2024), Summit Therapeutics's return on invested capital has grown at a -31.0% compound annual growth rate (CAGR), from -361.7% to -81.8%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Summit Therapeutics's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude